Eccogene
Clinical trials sponsored by Eccogene, explained in plain language.
-
New drug combo aims to shrink fatty liver in MASH patients
Disease control Recruiting nowThis study tests two experimental drugs, ECC4703 and ECC0509, alone or together, to see if they can reduce liver fat in adults with MASH (a type of fatty liver disease). About 160 participants will receive either the drugs or a placebo for 12 weeks. The main goal is to measure ch…
Phase: PHASE2 • Sponsor: Eccogene • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Healthy volunteers needed to test new fatty liver Drug's absorption
Knowledge-focused Recruiting nowThis early-stage study enrolls 72 healthy adults to see if taking ECC4703 with food changes how the body absorbs it, and to compare four different pill versions. Participants receive a single dose and are monitored for safety and drug levels in the blood. The drug is being develo…
Phase: PHASE1 • Sponsor: Eccogene • Aim: Knowledge-focused
Last updated May 17, 2026 05:31 UTC